# clm_BA3B03AF2A85

subject: Amgen (/record/amgen.md)  
predicate: quarterly_revenue  
value: 8,618,000,000 United States dollar  
valid_from: 2026-03-31  
valid_to: 2026-06-30  
published: 2026-05-01  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_EE4AA58E7ACE  
last_updated: 2026-11-08  
cite: AsOf. "Amgen quarterly revenue: 8,618,000,000 United States dollar", as of 2026-03-31 (until 2026-06-30). Claim clm_BA3B03AF2A85, https://asof.is/claim/clm_BA3B03AF2A85, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/318154/000031815426000057/0000318154-26-000057-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q1 FY2026, filed 2026-05-01  

## Sources

- https://www.sec.gov/Archives/edgar/data/318154/000031815426000057/0000318154-26-000057-index.htm (primary, SEC EDGAR 10-Q Q1 FY2026, published 2026-05-01)

## Supersedes

- [Amgen](/record/amgen.md) | quarterly_revenue | 9,557,000,000 United States dollar | valid 2025-09-30 to 2026-03-31 | conf 0.95 | superseded | superseded_by [clm_BA3B03AF2A85](/claim/clm_BA3B03AF2A85.md) | [clm_56EFD8BFD444](/claim/clm_56EFD8BFD444.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.